Condition: Coronary Artery Disease · Ischemic Heart Disease · Sponsor: Fundación EPIC
Single center, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Essential Pro to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTIVE patients treated with Essential Pro.
This description comes directly from the study's public registry record.
FUNDACION EPIC · 0034987225638 · iepic@fundacionepic.org
Always discuss trial participation with your own doctor first.
| Princess Margaret Hospital | Lai Chi Kok, Hong Kong | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06631157